Arena Pharmaceuticals, Inc.

Good day, everyone, and welcome to ARENA Pharmaceuticals corporate conference call. This call is being recorded. I will now turn the call over to Mr. Patrick Malloy, Vice President, Investor Relations at ARENA Pharmaceuticals. Please go ahead, sir.

Great. Thank you, Delphin, and good afternoon, everyone. Thanks for joining us today, and we hope you had a chance to review the press release we issued this afternoon announcing our first quarter 2021 financial results. Joining me on today's call are Amit Munshi, our President and Chief Executive Officer, and Lori Stelzer, our Chief Financial Officer. Before we begin, I'd like to remind you that we'll be making forward-looking statements that involve risks and uncertainties about our goals, expectations, plans, beliefs, timing of events or future results, including those risks and uncertainties related to our pipeline, financial projections, 2021 financial guidance, and the COVID-19 pandemic and its potential impact on our business. Forward-looking statements involve certain assumptions, risks, and uncertainties that may be beyond our control and could cause actual results to differ materially from these statements. A description of these risks can be found in our earnings press release and our latest SEC disclosure documents. All forward-looking statements are based on information currently available to ARENA and we disclaim any obligation to a to update these forward-looking statements. Now, I'd like to turn the call over to Amit Munshi. Amit?

Thanks, Pat, and thanks, everyone, for joining the call today. And again, as Pat mentioned, I hope you had a chance to review the press release outlining our strong progress during the last quarter. As we did last quarter, we're going to move directly to Q&A and have – I'm going to jump right to that and be able to spend more time there. So with that, I'm going to hand it back to the operator to open the Q&A portion.